Page last updated: 2024-11-05

thiotepa and Leukemia, Monocytic, Acute

thiotepa has been researched along with Leukemia, Monocytic, Acute in 1 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Leukemia, Monocytic, Acute: An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Silberberg, JM1
Zarrabi, MH1

Other Studies

1 other study available for thiotepa and Leukemia, Monocytic, Acute

ArticleYear
Acute nonlymphocytic leukemia after thiotepa instillation into the bladder: report of 2 cases and review of the literature.
    The Journal of urology, 1987, Volume: 138, Issue:2

    Topics: Administration, Intravesical; Aged; Carcinoma, Papillary; Carcinoma, Transitional Cell; Humans; Leuk

1987